Biogen
BIIB
BIIB
979 hedge funds and large institutions have $32.7B invested in Biogen in 2022 Q3 according to their latest regulatory filings, with 150 funds opening new positions, 275 increasing their positions, 367 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
979
Holders Change
+59
Holders Change %
+6.41%
% of All Funds
16.93%
Holding in Top 10
21
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+61.54%
% of All Funds
0.36%
New
150
Increased
275
Reduced
367
Closed
79
Calls
$2.02B
Puts
$1.87B
Net Calls
+$153M
Net Calls Change
+$209M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$326M |
| 2 |
Man Group
London,
United Kingdom
|
+$179M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$134M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$120M |
| 5 |
Millennium Management
New York
|
+$88.4M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$307M |
| 2 |
BlackRock
New York
|
-$165M |
| 3 |
IIM
INTECH Investment Management
West Palm Beach,
Florida
|
-$106M |
| 4 |
Renaissance Technologies
New York
|
-$105M |
| 5 |
HM
HealthCor Management
New York
|
-$91.8M |